Hej..jeg har et frimærke i danske Saniona, der er noteret på Aktietorvet i Stockholm - i de sidste par uger er den steget næsten 100 % - er der nogen der følger aktien og kan give en melding om jeg skal investere yderligere i aktien ?
22. marts 2016 har selskabet udsendt en pressemeddelelse hvor essensen er følgende:
"Our vision for Tesomet is to develop a new type of treatment for diabetes, which can bring certain groups of patients in complete remission by contributing to a substantial weight loss through decreased food consumption," says Jørgen Drejer, CEO of Saniona."
"Our vision for Tesomet is to develop a new type of treatment for diabetes, which can bring certain groups of patients in complete remission by contributing to a substantial weight loss through decreased food consumption," says Jørgen Drejer, CEO of Saniona."
